Chugai Phrma (CHGCY) Stock Price, News & Analysis
Company Description
Chugai Phrma (OTC Link: CHGCY) is classified in the drug manufacturers - general industry within the Healthcare sector and carries a market capitalization of $74.6B.
CHGCY has declined 13.2% over the past year. Shares last traded at $21.42.
This page collects what Stock Titan holds for CHGCY, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Chugai Phrma (CHGCY) stock last closed at $21.42. Over the past 12 months, the stock has lost 13.2%. At a market capitalization of $74.6B, CHGCY is classified as a large-cap stock with approximately 3.3B shares outstanding.
Latest News
Chugai Phrma has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 5 with negative movement. Key topics include fda approval, partnership, clinical trial, conferences. View all CHGCY news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Chugai Phrma (CHGCY) currently stands at 63.9 thousand shares, up 109.1% from the previous reporting period, representing 0.0% of the float. Since July 2025, short interest has decreased by 42.4%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Chugai Phrma (CHGCY) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
CHGCY Company Profile & Sector Positioning
Chugai Phrma (CHGCY) operates in the Drug Manufacturers - General industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing CHGCY often look at related companies in the same sector, including Daiichi Sankyo (DSNKY), Bayer Aktien (BAYRY), Bayer A G (BAYZF), Otsuka Holdings (OTSKY), and Otsuka Holdings (OTSKF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CHGCY's relative position within its industry.